Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Marjorie A. Bowman et al.|The Lancet|2016Cited by 327
Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineagesCarmen G. Palii, Marjorie Brand, Carolina Perez‐Iratxeta et al.|The EMBO Journal|2010Cited by 142
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Harold Atkins et al.|JAMA Neurology|2016Cited by 103
Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaLaura Labonté, David Allan, Tariq Iqbal et al.|Transplantation and Cellular Therapy|2008Cited by 55
Autologous Stem Cell Transplantation for Stiff Person SyndromeSheilagh Sanders, Harold Atkins, Christopher Bredeson et al.|JAMA Neurology|2014Cited by 46